IL1B and COVID-19: When stimulated in vitro, the monocytes from COVID-19 patients synthesized significantly lower levels of pro-inflammatory cytokines IL-1β, TNFα, IL-6, and MCP-1, compared to the cells obtained from apparently healthy donors [35].